0001209191-20-047246.txt : 20200818 0001209191-20-047246.hdr.sgml : 20200818 20200818173322 ACCESSION NUMBER: 0001209191-20-047246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200817 FILED AS OF DATE: 20200818 DATE AS OF CHANGE: 20200818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Dowd Sarah A CENTRAL INDEX KEY: 0001447149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 201114691 MAIL ADDRESS: STREET 1: 3185 LAURELVIEW COURT CITY: FREMONT STATE: CA ZIP: 94538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-17 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001447149 O'Dowd Sarah A C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BOULEVARD, SUITE 140 NEWARK CA 94560 1 0 0 0 Stock Option (right to buy) 16.50 2020-08-17 4 A 0 30000 0.00 A 2030-08-16 Common Stock 30000 30000 D The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of August 12, 2020. /s/ Donald Kalkofen, Attorney-in-Fact for Sarah A. O'Dowd 2020-08-18